https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-06-01 / Clin. Cancer Res. 1999 Jun;5(6):1331-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-06-01 / Clin. Cancer Res. 1999 Jun;5(6):1331-81999-06-01 00:00:002019-02-15 08:39:12A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-05-05 / JAMA 1999 May;281(17):1588-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-05-05 / JAMA 1999 May;281(17):1588-91999-05-05 00:00:002019-02-15 09:00:19Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-04-01 / J. Immunol. 1999 Apr;162(7):3757-60
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-04-01 / J. Immunol. 1999 Apr;162(7):3757-601999-04-01 00:00:002019-02-15 09:18:04Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-03-01 / Int J Hyperthermia 1999 Mar-Apr;15(2):79-107
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-03-01 / Int J Hyperthermia 1999 Mar-Apr;15(2):79-1071999-03-01 00:00:002019-02-15 09:17:58For the clinical application of thermochemotherapy given at mild temperatures
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-03-01 / J. Urol. 1999 Mar;161(3):777-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-03-01 / J. Urol. 1999 Mar;161(3):777-821999-03-01 00:00:002019-02-15 08:48:12Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-02-01 / Int. J. Oncol. 1999 Feb;14(2):205-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-02-01 / Int. J. Oncol. 1999 Feb;14(2):205-151999-02-01 00:00:002020-06-23 09:46:02Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-09 / Ned Tijdschr Geneeskd 1999 Jan;143(2):85-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-09 / Ned Tijdschr Geneeskd 1999 Jan;143(2):85-81999-01-09 00:00:002019-02-15 09:18:00[Hyperthermia in combination with chemotherapy in gynecological cancers]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-01 / Gene Ther. 1999 Jan;6(1):63-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-01 / Gene Ther. 1999 Jan;6(1):63-731999-01-01 00:00:002020-06-23 09:46:30Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-01 / Infect Dis Obstet Gynecol 1999;7(1-2):91-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-01 / Infect Dis Obstet Gynecol 1999;7(1-2):91-71999-01-01 00:00:001999-01-01 00:00:00Characterization of mild whole-body hyperthermia protocols using human breast, ovarian, and colon tumors grown in severe combined immunodeficient mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-01 / Urol Int 1999;63(3):151-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-01 / Urol Int 1999;63(3):151-91999-01-01 00:00:001999-01-01 00:00:00Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma
